NLRP3 and gout: In this line, β-carotene administered orally (30 mg/kg) inhibited NLRP3 inflammasome activation in a model of gouty arthritis in mice, as well as suppressed levels of IL-1β in synovial fluid cells isolated from gout patients [127].